Details
Stereochemistry | RACEMIC |
Molecular Formula | C23H29F3O6 |
Molecular Weight | 458.468 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@@H](COC1=CC(=CC=C1)C(F)(F)F)\C=C\[C@H]2[C@H](O)C[C@H](O)[C@@H]2C\C=C/CCCC(O)=O
InChI
InChIKey=WWSWYXNVCBLWNZ-QIZQQNKQSA-N
InChI=1S/C23H29F3O6/c24-23(25,26)15-6-5-7-17(12-15)32-14-16(27)10-11-19-18(20(28)13-21(19)29)8-3-1-2-4-9-22(30)31/h1,3,5-7,10-12,16,18-21,27-29H,2,4,8-9,13-14H2,(H,30,31)/b3-1-,11-10+/t16-,18-,19-,20+,21-/m1/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. | 1997 Sep |
|
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. | 2000 Jan 17 |
|
Prostaglandins differently regulate FGF-2 and FGF receptor expression and induce nuclear translocation in osteoblasts via MAPK kinase. | 2005 Feb |
|
Niacin promotes adipogenesis by reducing production of anti-adipogenic PGF2α through suppression of C/EBPβ-activated COX-2 expression. | 2011 Apr |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C78568
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
60782
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
358S7VUE5N
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
3794
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
255-029-3
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
C76900
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
CHEMBL2220419
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
40666-16-8
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
100000080744
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
DB11519
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
m5494
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB07740MIG
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
DTXSID7046122
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY | |||
|
5311100
Created by
admin on Fri Dec 15 15:49:04 GMT 2023 , Edited by admin on Fri Dec 15 15:49:04 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)